Results 121 to 130 of about 488,838 (371)

Prevalence of inflammatory bowel disease among coeliac disease patients in a Hungarian coeliac centre [PDF]

, 2015
BACKGROUND: Celiac disease, Crohn disease and ulcerative colitis are inflammatory disorders of the gastrointestinal tract with some common genetic, immunological and environmental factors involved in their pathogenesis.
A Culliford, A Diamanti, A Shah, A Yang, AP Keaveny, B Annibale, BT Cooper, C Tirpitz Von, CC Cronin, CL Wright, D Kocsis, DD Mijac, Dorottya Kocsis, DR Duerksen, EA Festen, EC Oxford, EG Breen, F Delcò, G Casella, G Casella, G Kitis, J Patel, JA Snook, JS Leeds, JS Siffledeen, László Herszényi, M Cottone, M Durusu, M Masachs, M Tola Di, MD Schuffler, MG Farrace, Miklós Tóth, MK Nusier, ML Bianchi, Márk Juhász, N Bizzaro, PH Green, PL Lakatos, Pál Miheller, Péter Pák, S Husby, S Vermeire, SX Cheng, W Dickey, W Dickey, Zsolt Tulassay, Zsuzsanna Tóth, Ágnes A. Csontos   +48 more
core   +1 more source

Intraoral Drug Delivery: Bridging the Gap Between Academic Research and Industrial Innovations

Advanced Functional Materials, EarlyView.
Intraoral drug delivery offers a promising route for systemic and localized therapies, yet challenges such as enzymatic degradation, limited permeability, and microbial interactions hinder efficacy. This figure highlights innovative strategies—mucoadhesive materials, enzyme inhibitors, and permeation enhancers—to overcome these barriers.
Soheil Haddadzadegan, Simona Summonte, Fabrizio Ricci, Matthias Sandmeier, Andreas Bernkop‐Schnürch   +4 more
wiley   +1 more source

A new recurrent neural network based predictive model for Faecal Calprotectin analysis: A retrospective study [PDF]

arXiv, 2016
Faecal Calprotectin (FC) is a surrogate marker for intestinal inflammation, termed Inflammatory Bowel Disease (IBD), but not for cancer. In this retrospective study of 804 patients, an enhanced benchmark predictive model for analyzing FC is developed, based on a novel state-of-the-art Echo State Network (ESN), an advanced dynamic recurrent neural ...
arxiv  

Inflammatory bowel diseases [PDF]

DMW - Deutsche Medizinische Wochenschrift, 2004
M. Zeitz, Hans Scherübl, B. M. Wittig, J. C. Hoffmann   +3 more
openaire   +7 more sources

Inflammatory bowel disease in the West Indies. [PDF]

, 1979
C Bartholomew, Andrew J. Butler
openalex   +3 more sources

Probiotic‐Based Mineralized Living Materials to Produce Antimicrobial Yogurts

Advanced Healthcare Materials, EarlyView.
The self‐assembly and mineralization of collagen in the presence of probiotics produces hybrid living materials that hosts and protects the cells. Intra‐ and interfibrillar mineralization of collagen fibers, as occurring in bone, results, respectively, in a bulk and single‐cell protective layer of cells, that survive in simulated gastric conditions and,
Gloria B. Ramírez‐Rodríguez, Laura Sabio, Laura Cerezo‐Collado, Víctor Garcés, Jose M. Domínguez‐Vera, José M. Delgado‐López   +5 more
wiley   +1 more source

Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease [PDF]

, 1974
Bronwyn West, R Lendrum, Michael J. Hill, G Walker   +3 more
openalex   +1 more source

Inflammatory bowel disease [PDF]

Alimentary Pharmacology & Therapeutics, 2003
R. W. Stockbrugger, M. R. B. Keighley
openaire   +4 more sources

“Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

Advanced Healthcare Materials, EarlyView.
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray, Shehzahdi S. Moonshi, Hang Thu Ta   +2 more
wiley   +1 more source

Survey of Perceptions and Practices among Canadian Gastroenterologists regarding the Prevention of Venous Thromboembolism for Hospitalized Inflammatory Bowel Disease Patients

Canadian Journal of Gastroenterology, 2012
BACKGROUND: Patients with inflammatory bowel disease (IBD) who are hospitalized with disease flares are known to be at an increased risk of venous thromboembolism (VTE).
Roshan Razik, Charles N Bernstein, Justina Sam, Reka Thanabalan, Geoffrey C Nguyen   +4 more
doaj   +1 more source